[Studies on anti-inflammatory agents. IV. On the appearance of physical dependence and analgesic activity of 2-amino-3-ethoxycarbonyl-6-benzyl-4,5,6-7-tetrahydrothieno(2,3-c)pyridine (Y-3642) by repeated administration].
D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001835:Body Weight / Q000187:drug effects; D004032:Diet; D004361:Drug Tolerance; D006801:Humans; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D007977:Levallorphan / Q000008:administration & dosage / Q000494:pharmacology; D008297:Male; D009020:Morphine / Q000494:pharmacology; D010146:Pain; D011725:Pyridines / Q000008:administration & dosage* / Q000494:pharmacology; D051381:Rats; D019966:Substance-Related Disorders; D013438:Sulfhydryl Compounds / Q000008:administration & dosage*; D013876:Thiophenes / Q000008:administration & dosage / Q000494:pharmacology; D014867:Water
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D011725:Pyridines; D013438:Sulfhydryl Compounds; D013876:Thiophenes; D014867:Water; D007977:Levallorphan; D009020:Morphine